This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Almac House. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Steven D Shepherd: Innovator in Cancer Treatment
Introduction
Steven D Shepherd is a notable inventor based in Craigavon, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on creating effective inhibitors for specific kinases involved in cancer progression.
Latest Patents
One of Steven D Shepherd's key patents is titled "Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors." This invention relates to compounds that inhibit the activity of Wee-1 kinase, which plays a crucial role in cell cycle regulation. The patent also encompasses pharmaceutical compositions that include these compounds and outlines methods for using them in cancer treatment.
Career Highlights
Throughout his career, Steven has worked with prominent organizations such as Almac House and Almac Discovery Limited. His experience in these companies has allowed him to advance his research and contribute to the development of innovative cancer therapies.
Collaborations
Steven has collaborated with notable professionals in his field, including Colin Roderick O'Dowd and Hugues Miel. These partnerships have further enriched his research and development efforts.
Conclusion
Steven D Shepherd is a dedicated inventor whose work in developing Wee-1 kinase inhibitors has the potential to significantly impact cancer treatment. His contributions to pharmaceutical innovation highlight the importance of research in advancing medical science.